The supplementation of cyanidin and delphinidin effectively controlled overweight, obesity, and type 2 diabetes by modulating the activity of inflammatory mediators, oxidative stress, and NF-κB/JNK activation [85]. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.